{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:32:35Z","timestamp":1785717155719,"version":"3.56.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","award":["VEAP 10011"],"award-info":[{"award-number":["VEAP 10011"]}],"id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.vaccine.2022.06.068","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:44:54Z","timestamp":1657068294000},"page":"4856-4863","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Pneumococcal vaccination coverage among adults newly diagnosed with underlying medical conditions and regional variation in the U.S."],"prefix":"10.1016","volume":"40","author":[{"given":"Anna","family":"Ostropolets","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Shoener Dunham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly D.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3517-6957","authenticated-orcid":false,"given":"Junqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.06.068_b0005","article-title":"Rates of pneumococcal disease in adults with chronic medical conditions. open forum","volume":"1","author":"Shea","year":"2014","journal-title":"Infect Dis"},{"key":"10.1016\/j.vaccine.2022.06.068_b0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40121-014-0025-y","article-title":"Epidemiology of pneumococcal disease in a national cohort of older adults","volume":"3","author":"Morrill","year":"2014","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.vaccine.2022.06.068_b0015","unstructured":"Pneumococcal Disease Surveillance Reporting and Trends | CDC 2021. https:\/\/www.cdc.gov\/pneumococcal\/surveillance.html (accessed December 4, 2021))."},{"key":"10.1016\/j.vaccine.2022.06.068_b0020","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1080\/14787210.2021.1858799","article-title":"Predictors of mortality in invasive pneumococcal disease: a meta-analysis","volume":"19","author":"Demirdal","year":"2021","journal-title":"Expert Rev Anti-Infective Ther"},{"key":"10.1016\/j.vaccine.2022.06.068_b0025","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12913-016-1432-4","article-title":"Rates and costs of invasive pneumococcal disease and pneumonia in persons with underlying medical conditions","volume":"16","author":"Weycker","year":"2016","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.vaccine.2022.06.068_b0030","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10935-015-0394-3","article-title":"Estimated human and economic burden of four major adult vaccine-preventable diseases in the United States, 2013","volume":"36","author":"McLaughlin","year":"2015","journal-title":"J Primary Prevent"},{"issue":"11","key":"10.1016\/j.vaccine.2022.06.068_b0035","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1377\/hlthaff.2016.0462","article-title":"Modeling the economic burden of adult vaccine-preventable diseases in the United States","volume":"35","author":"Ozawa","year":"2016","journal-title":"Health Aff"},{"key":"10.1016\/j.vaccine.2022.06.068_b0040","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1513\/AnnalsATS.201511-778FR","article-title":"Pneumococcal vaccination strategies","volume":"13","author":"Berical","year":"2016","journal-title":"Update Perspect Ann ATS"},{"key":"10.1016\/j.vaccine.2022.06.068_b0045","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.15585\/mmwr.mm6846a5","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged \u226565 years: updated recommendations of the advisory committee on immunization practices","volume":"68","author":"Matanock","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2022.06.068_b0050","unstructured":"Advisory Committee on Immunization Practices (ACIP) | CDC 2021. https:\/\/www.cdc.gov\/vaccines\/acip\/index.html (accessed December 4, 2021)."},{"key":"10.1016\/j.vaccine.2022.06.068_b0055","unstructured":"Immunization and Infectious Diseases | Healthy People 2020 n.d. https:\/\/www.healthypeople.gov\/2020\/topics-objectives\/topic\/Immunization-and-Infectious-Diseases\/objectives#4670 (accessed December 4, 2021)."},{"key":"10.1016\/j.vaccine.2022.06.068_b0060","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/aje\/kwr376","article-title":"Uptake of pneumococcal polysaccharide vaccination among working-age adults with underlying medical conditions, United States, 2009","volume":"175","author":"Lu","year":"2012","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2022.06.068_b0065","doi-asserted-by":"crossref","first-page":"8073","DOI":"10.1016\/j.vaccine.2011.08.051","article-title":"Pharmacists as providers: targeting pneumococcal vaccinations to high risk populations","volume":"29","author":"Taitel","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.06.068_b0070","doi-asserted-by":"crossref","first-page":"e50553","DOI":"10.1371\/journal.pone.0050553","article-title":"Vaccination rates among the general adult population and high-risk groups in the United States","volume":"7","author":"Annunziata","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2022.06.068_b0075","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jiph.2019.06.010","article-title":"Missed opportunities for pneumococcal vaccinations in high-risk and older adults in the United States","volume":"13","author":"Olasupo","year":"2020","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.vaccine.2022.06.068_b0080","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.amepre.2018.01.033","article-title":"Pneumococcal vaccine coverage in adults aged 19\u201364 years, newly diagnosed with chronic conditions in the U.S","volume":"54","author":"Petigara","year":"2018","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2022.06.068_b0085","unstructured":"Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Data 2020."},{"key":"10.1016\/j.vaccine.2022.06.068_b0090","unstructured":"IBM Watson Health and MarketScan are trademarks of IBM Corporation in the United States, other countries, or both. n.d."},{"key":"10.1016\/j.vaccine.2022.06.068_b0095","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1136\/thoraxjnl-2015-206780","article-title":"Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and\/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease: Table 1","volume":"70","author":"Torres","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.vaccine.2022.06.068_b0100","series-title":"Integrated diabetes care: a multidisciplinary approach","author":"Simmons","year":"2016"},{"issue":"3","key":"10.1016\/j.vaccine.2022.06.068_b0105","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3810\/pgm.2012.05.2550","article-title":"Identifying barriers to adult pneumococcal vaccination: an NFID task force meeting","volume":"124","author":"Rehm","year":"2012","journal-title":"Postgrad Med"},{"key":"10.1016\/j.vaccine.2022.06.068_b0110","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.amjmed.2008.05.005","article-title":"Barriers to adult immunization","volume":"121","author":"Johnson","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.vaccine.2022.06.068_b0115","unstructured":"Centers for Disease and Control Prevention. State Hospital Influenza Vaccination Laws 2015. https:\/\/www.cdc.gov\/phlp\/docs\/menu-shfluvacclaws.pdf (accessed December 27, 2021)."},{"key":"10.1016\/j.vaccine.2022.06.068_b0120","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/tbm\/ibx076","article-title":"Privately insured adults in HDHP with higher deductibles reduce rates of primary care and preventive services","volume":"8","author":"Jetty","year":"2018","journal-title":"Translational Behav Med"},{"key":"10.1016\/j.vaccine.2022.06.068_b0125","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1007\/s10900-012-9567-7","article-title":"Underinsurance for recently recommended vaccines in private health plans","volume":"37","author":"Singer","year":"2012","journal-title":"J Community Health"},{"key":"10.1016\/j.vaccine.2022.06.068_b0130","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ypmed.2015.07.012","article-title":"Has recommended preventive service use increased after elimination of cost-sharing as part of the Affordable Care Act in the United States?","volume":"78","author":"Han","year":"2015","journal-title":"Prev Med"},{"key":"10.1016\/j.vaccine.2022.06.068_b0135","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1377\/hlthaff.2012.0059","article-title":"In consumer-directed health plans, a majority of patients were unaware of free or low-cost preventive care","volume":"31","author":"Reed","year":"2012","journal-title":"Health Aff"},{"key":"10.1016\/j.vaccine.2022.06.068_b0140","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/14760584.2021.1898377","article-title":"Pneumococcal vaccination coverage among adults aged 19 to 64 years with immuno-compromising conditions, cerebrospinal fluid (CSF) leaks, or cochlear implants in the US","volume":"20","author":"Deb","year":"2021","journal-title":"Expert Rev Vaccines"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22008374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22008374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:32:31Z","timestamp":1778679151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22008374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":28,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0264410X22008374"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.06.068","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pneumococcal vaccination coverage among adults newly diagnosed with underlying medical conditions and regional variation in the U.S.","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.06.068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}